Partners
Our work is made possible through smart, effective partnerships. GARDP brings together governments, the pharmaceutical and biotech industry, academia, and civil society to develop treatments for drug-resistant infections, and to ensure they are available for every person who needs them.
“Tackling the threat of drug-resistant infections requires an urgent and truly global response. Critical to achieving this is GARDP’s public-private partnership approach and commitment to ensuring new and improved antibiotics are available for every person who needs them, wherever they live.”
– Glenda Gray, President & CEO, South African Medical Research Council, member of the GARDP Board
Forging a global network to counter antibiotic resistance
GARDP currently works with more than 70 partners in over 20 countries.
Supporting GARDP to stop the spread of drug-resistant infections
Supporting GARDP to stop the spread of drug-resistant infections
GARDP receives essential funding from around the world. Thank you for your commitment to fighting antibiotic resistance in partnership with GARDP.
